HSK3486: Clinical Trials

33 trials of HSK3486, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 15 Phase 1, 9 Phase 3, 5 Phase 2, 2 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 115Completed 14, Withdrawn 1
Phase 39Completed 8, Not yet recruiting 1
Phase 25Completed 5
Not applicable2Unknown 2
Phase 42Recruiting 2

Follow HSK3486: new trials by email Literature Review of HSK3486 trials Research Report on HSK3486

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery
HSK3486, propofol - General Anesthetic
Phase 3Not yet recruitingHaisco Pharmaceutical Group Co., Ltd.4002026-05-012026-04-06
Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery
Propofol, ciprofol - Myocardial Injury, Thoracic Diseases
Phase 4RecruitingTongji Hospital10582025-07-312026-01-28
A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective Surgery
Cipepofol - Anesthesia
Phase 4RecruitingHaisco Pharmaceutical Group Co., Ltd.402025-01-062025-01-27
Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)
HSK3486, Moxifloxacin Hydrochloride, Placebo - Anesthesia; Adverse Effect, Cardiac Arrhythmia
Phase 1CompletedHaisco-USA Pharmaceuticals, Inc.482024-04-092026-01-13
Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery
HSK3486, Propofol - General Anesthesia
Phase 3CompletedHaisco-USA Pharmaceuticals, Inc.4652024-01-122025-10-10
Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation
Propofol, Ciprofol - Liver Cancer, Ciprofol
Not applicableUnknownZhejiang Cancer Hospital802023-08-012023-12-21
Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of Recovery
Ciprofol, Propofol - Anesthetics, Intravenous, Postoperative Complications
Not applicableUnknownXijing Hospital2802023-05-162024-04-09
Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users
HSK3486, Propofol, Placebo - General Anesthesia
Phase 1CompletedHaisco-USA Pharmaceuticals, Inc.422022-08-162023-10-13
Part 1: Dose-Finding of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users
HSK3486, propofol, Placebo - General Anesthesia
Phase 1CompletedHaisco-USA Pharmaceuticals, Inc.432022-08-162026-02-23
Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia
HSK3486, Propofol - General Anesthesia
Phase 3CompletedHaisco-USA Pharmaceuticals, Inc.4002022-07-262025-10-10
A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation
HSK3486, Propofol - Sedation in Intensive Care
Phase 2CompletedHaisco Pharmaceutical Group Co., Ltd.202021-03-092022-05-27
Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery
HSK3486, Propofol - Anesthesia
Phase 3CompletedHaisco-USA Pharmaceuticals, Inc.2552021-02-112025-10-10
A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical Ventilation
HSK3486, Propofol - Sedation in Intensive Care
Phase 3CompletedHaisco Pharmaceutical Group Co., Ltd.1352020-12-082022-05-27
A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia
HSK3486, Propofol - Induction and Maintenance of General Anesthesia
Phase 3CompletedHaisco Pharmaceutical Group Co., Ltd.1292020-11-242022-05-31
A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy Adults
HSK3486 - Anesthesia, Sedation
Phase 1WithdrawnSichuan Haisco Pharmaceutical Group Co., Ltd2020-03-302022-06-02
Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions
HSK3486 - Chronic Renal Impairment
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd242020-01-052020-12-19
Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Healthy Elderly Subjects
HSK3486 - Healthy Elderly Subjects
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd322019-12-252020-12-17
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets
HSK3486, voriconazole +HSK3486 - Anesthesia, Sedation
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd162019-12-142020-12-19
A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery Patients
HSK3486, Propofol, Propofol HSK3486 - Induction and Maintenance of General Anesthesia
Phase 2CompletedSichuan Haisco Pharmaceutical Group Co., Ltd462019-12-092020-12-17
A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Subjects Undergoing Fiberoptic Bronchoscopy
HSK3486, Propofol - Sedation or Anesthesia
Phase 3CompletedSichuan Haisco Pharmaceutical Group Co., Ltd2672019-12-062020-12-17

Showing 20 of 33. Sign in to see all of them.

Conditions studied

Arrhythmias, Cardiac (1)  ·  Liver Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Postoperative Complications (1)  ·  Renal Insufficiency, Chronic (1)  ·  Thoracic Diseases (1)

Sponsors

Sichuan Haisco Pharmaceutical Group Co., Ltd (19)  ·  Haisco-USA Pharmaceuticals, Inc. (6)  ·  Haisco Pharmaceutical Group Co., Ltd. (5)  ·  Tongji Hospital (1)  ·  Xijing Hospital (1)  ·  Zhejiang Cancer Hospital (1)

Countries

China (22)  ·  United States (5)  ·  Poland (1)  ·  Spain (1)

Top investigators

Gao Jingui, Doctor (1)  ·  Haopeng Zhang (1)  ·  Jiangling Wang, Dr. (1)  ·  Liyan Miao, PhD (1)  ·  William Daley, MD (1)  ·  Yan-hua Ding, PhD (1)  ·  Yanhua Ding, PhD (1)

Results publications

PMID 28430430, PMID 29203498, PMID 32415708, PMID 34417990, PMID 34601955, PMID 35157236, PMID 36217101, PMID 36647565, PMID 36680620, PMID 37272947, PMID 38074142, PMID 39455495, PMID 41836529, PMID 41858914